Studies adults with COPD and heart disease in Greece over time
Observes Greek adults with lung and heart disease to track their health and care.
Plain-language title generated from the registry record
Registry title: The HELlenic Thoracic Society Initiative for CΟPD and CVD
Key facts
- Where
- Alexandroupoli and Athens, GreeceSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 35 and 99 years old?
Source: NCT06595784, who can take part
Where in Greece
- Department of Respiratory Medicine, Medical School, Democritus University of Thrace, University General HospitalAlexandroupoli, GreeceTaking people
- 5th Pulmonary Department, "Sotiria" Chest Diseases Hospital, Athens, GreeceAthens, GreeceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Hellenic Thoracic Society
- Trial code
- NCT06595784
- Record updated
- 16 September 2026
- Original description
COPD is one of the most common respiratory diseases in Greece, and maybe more than half a million Greek citizens suffer both from COPD and CVD, however their characteristics and management remain unknown. HELICOPD is a national, multicenter, prospective, non-interventional study designed to contribute to better understanding and depicting the demographic and clinical characteristics of this population, the COPD- and CVD-related adverse events in a two-years period, their quality of life and the healthcare resources use. The study is initiated and coordinated by the Hellenic Thoracic Society.Read full original descriptionShow less
The HELlenic Thoracic Society Initiative for CΟPD and CVD
COPD is one of the most common respiratory diseases in Greece, and maybe more than half a million Greek citizens suffer both from COPD and CVD, however their characteristics and management remain unknown. HELICOPD is a national, multicenter, prospective, non-interventional study designed to contribute to better understanding and depicting the demographic and clinical characteristics of this population, the COPD- and CVD-related adverse events in a two-years period, their quality of life and the healthcare resources use. The study is initiated and coordinated by the Hellenic Thoracic Society.
Inclusion: Patients should cumulatively meet the following three (3) criteria to be enrolled in the study:; To have been diagnosed with chronic obstructive pulmonary disease and at least one cardiovascular comorbidity (heart failure, atherosclerotic cardiovascular disease, atrial Fibrillation, severe valvular disease); Adults aged \>35 years at the time of inclusion in the study,; With signed informed consent for their participation in the study. Exclusion criteria Patients with the below limitations are not eligible to participate in the study; Patients:; Without at least one cardiovascular comorbidity,; With history of lung cancer; With any other active malignancy and undergoing treatment (chemotherapy/radiotherapy/immunotherapy); With any thoracic or abdominal surgery planned during study follow-up period; With participation in any COPD-related interventional study at study entry or during study duration; Without signed informed consent for their participation in the study.